Evidence map›Paper›PMID 38582886›Full record

ArticleOrphanet journal of rare diseases2024

Identification and characterization of a new pathologic mutation in a large Leber hereditary optic neuropathy pedigree.

Sonia Emperador, Mouna Habbane, Ester López-Gallardo, Alejandro Del Rio, Laura Llobet, Javier Mateo, Ana María Sanz-López, María José Fernández-García, Hortensia Sánchez-Tocino, Sol Benbunan-Ferreiro and 10 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sonia Emperador *Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Mouna Habbane *Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Ester López-GallardoDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Alejandro Del RioDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Laura LlobetDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Javier MateoServicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, 50009, Zaragoza, Spain.
Ana María Sanz-LópezServicio de Oftalmología, Hospital Universitario de Toledo, 45004, Toledo, Spain.
María José Fernández-GarcíaServicio de Oftalmología, Hospital Universitario de Toledo, 45004, Toledo, Spain.
Hortensia Sánchez-TocinoServicio de Oftalmología. Hospital Universitario Río Hortega, 47012, Valladolid, Spain.
Sol Benbunan-FerreiroServicio de Oftalmología. Hospital Universitario Río Hortega, 47012, Valladolid, Spain.
María Calabuig-GoenaServicio de Oftalmología. Hospital Universitario Río Hortega, 47012, Valladolid, Spain.
Carlos Narvaez-PalazónInstituto Oftalmológico Recoletas, 47004, Valladolid, Spain.
Beatriz Fernández-VegaInstituto Oftalmológico Fernández-Vega, 33012-Oviedo, Asturias, Spain.
Hector González-IglesiasInstituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Científicas (IPLA-CSIC), 33300-Villaviciosa, Asturias, Spain.
Roser UrreiztiCentro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Rafael ArtuchCentro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
David Pacheu-GrauDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Pilar Bayona-BafaluyDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain.
Julio MontoyaDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain. jmontoya@unizar.es.
Eduardo Ruiz-PesiniDepartamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009- and 50013, Zaragoza, Spain. eduruiz@unizar.es.ORCID 0000-0002-0269-7337

Funding

Fundación Mutua Madrileña MMAGobierno de Aragón B33Gobierno de Aragón LMP22_21Instituto de Salud Carlos III FIS-PI20/00340Instituto de Salud Carlos III FIS-PI21/00229Ministerio de Ciencia e Innovación PID2020-116970GA-I00Ministerio de Ciencia e Innovación RYC2020-029544-IPrecipita-FECYT crowfunding program PR194
6 · The paper itself

Abstract

backgroundMost patients suffering from Leber hereditary optic neuropathy carry one of the three classic pathologic mutations, but not all individuals with these genetic alterations develop the disease. There are different risk factors that modify the penetrance of these mutations. The remaining patients carry one of a set of very rare genetic variants and, it appears that, some of the risk factors that modify the penetrance of the classical pathologic mutations may also affect the phenotype of these other rare mutations.

resultsWe describe a large family including 95 maternally related individuals, showing 30 patients with Leber hereditary optic neuropathy. The mutation responsible for the phenotype is a novel transition, m.3734A > G, in the mitochondrial gene encoding the ND1 subunit of respiratory complex I. Molecular-genetic, biochemical and cellular studies corroborate the pathogenicity of this genetic change.

conclusionsWith the study of this family, we confirm that, also for this very rare mutation, sex and age are important factors modifying penetrance. Moreover, this pedigree offers an excellent opportunity to search for other genetic or environmental factors that additionally contribute to modify penetrance.

Indexed as

DNA, MitochondrialOptic Atrophy, Hereditary, LeberHumansMutationPedigreePhenotypeDNA, MitochondrialIncomplete penetranceLarge pedigreeLeber hereditary optic neuropathyMitochondrial DNAPathologic mutation

Identifiers

PMID38582886
PMCPMC10999093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.